COMMUNIQUÉS West-GlobeNewswire

Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet
01/10/2026
DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
01/10/2026
Agreement establishes an initial 100-device commercialization program for the ANVISA-approved Nexalin Sync™ across seven countries and more than 300 million people, with a structured pricing framework and a mechanism [...]
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
01/10/2026
Brings public company CFO experience across commercial pharma and business development as Achieve prepares for potential commercialization of cytisinicline SEATTLE and VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE [...]
TOMI Environmental Solutions Expands SteraMist iHP into India's Pharmaceutical Market Through Partner STS Technocrat (India) Pvt. Ltd.
01/10/2026
STS Technocrat (India) Pvt. Ltd. signs a leading pharmaceutical customer and is building an integrated SteraMist iHP enclosure with TOMI to support growth across India FREDERICK, Md. , Oct. 01, 2026 (GLOBE NEWSWIRE) -- [...]
RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
01/10/2026
Case Series Reports Tumor Treatment Response, Significant Tumor Marker Reduction, and Changes on Imaging After Treatment with TAMP in Patients with Unresectable LAPC MOUNTAIN VIEW, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE [...]
Le SkinStylus® SteriLock MicroSystem de SkinHealth Systems désormais disponible sur le marché européen
01/10/2026
Le dispositif professionnel de microneedling et de nanoneedling fait son entrée au Royaume-Uni, en Irlande, en Allemagne, en France, en Espagne et au Portugal LONG BEACH, Californie, 01 oct. 2026 (GLOBE NEWSWIRE) -- [...]
SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe
01/10/2026
Professional microneedling and nano-needling device launches in UK, Ireland, Germany, France, Spain and Portugal LONG BEACH, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (Nasdaq: SKIN), home to flagship [...]
Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
01/10/2026
Company announcement – No. 52 / 2026 Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people [...]
Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
01/10/2026
In the SYNCHRONIZE-2 trial, which met its co-primary endpoints, participants achieved significant body weight reduction of up to 13.1% versus 3.1% in the placebo arm, after 76 weeks of treatment with survodutide in [...]
DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform
01/10/2026
New capabilities enable researchers to analyse, characterise and prioritise antibody candidates at scale Integrated AI models and workflows support better informed decisions about which antibodies to progress [...]
Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer to Advance its Proprietary Multispecific Antibody Pipeline
01/10/2026
Appointment brings extensive experience spanning drug discovery, translational medicine, clinical development and scientific leadership HORGEN, Switzerland, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Numab Therapeutics (“Numab [...]
Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body composition
01/10/2026
In the 8-week study, ATR-258 was well-tolerated and associated with an approximately 13% mean improvement in lower extremity muscle power in combination with a beneficial effect on body composition, with an increase in [...]
Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board
01/10/2026
Hanover, Germany, October 01, 2026 – Allogenetics today announced the appointment of Olaf Schermeier, PhD, as Chairman of its Advisory Board. Dr. Schermeier brings more than 25 years of industry experience, including [...]
National MS Society Launches Campaign to End MS, Declaring for the First Time: Ending MS Is Within Reach
01/10/2026
Five-year, $1 billion campaign to lead the way in ending MS, anchored by the Society's first-ever national research symposium and a landmark day of action in New York City NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The [...]
Communiqué de presse : Sanofi et Regeneron élargissent leur Alliance mondiale avec plusieurs anticorps immunologiques de nouvelle génération à action prolongée
01/10/2026
Sanofi et Regeneron élargissent leur Alliance mondiale avec plusieurs anticorps immunologiques de nouvelle génération à action prolongée REGN20423, un anticorps monoclonal anti-IL-13 à action prolongée en phase clinique [...]
Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies
01/10/2026
Sanofi and Regeneron expand global Alliance with multiple nex t-generation, long-acting immunology antibodies REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is [...]
Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine
01/10/2026
Giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1 -mutated populations, respectively, versus standard endocrine therapy plus everolimus 1 By targeting [...]
IBA et Telix renforcent leur collaboration avec un accord de distribution de la technologie QIS® d’ARTMS
01/10/2026
IBA proposera le système d’irradiation QUANTM ® aux utilisateurs de cyclotrons partout dans le monde, afin d’accélérer la production locale de radio-métaux destinés à la théranostique. Louvain-la-Neuve, Belgique, 01 [...]
IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS®
01/10/2026
IBA to offer QUANTM ® Irradiation System solid-target technology to cyclotron users worldwide, scaling local production of radiometals for theranostics Louvain-la-Neuve, Belgium – October 1st, 2026, 7 a.m. – IBA (Ion [...]

Pages